Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse.
Martinez-Recio S, Molina-Pérez MA, Muñoz-Couselo E, Sevillano-Tripero AR, Aya F, Arance A, Orrillo M, Martin-Liberal J, Fernandez-Morales L, Lesta R, Quindós-Varela M, Nieva M, Vidal J, Martinez-Perez D, Barba A, Majem M.
Martinez-Recio S, et al. Among authors: vidal j.
Cancers (Basel). 2025 Jan 5;17(1):143. doi: 10.3390/cancers17010143.
Cancers (Basel). 2025.
PMID: 39796770
Free PMC article.